ClinicalTrials.Veeva

Menu

TCM Etiological Study on the Theory of XuSunShengJi in Liver Cirrhosis

S

Shanghai University of Traditional Chinese Medicine

Status

Unknown

Conditions

Liver Cirrhosis

Treatments

Drug: Fuzhenghuayu Tablet, Huangqi Decoction Granule

Study type

Interventional

Funder types

Other

Identifiers

NCT00540397
2006CB504801

Details and patient eligibility

About

To Elucidate and Confirm the Theory of XuSunShengJi in the Traditional Chinese Medicine Etiological Pathogenesis of Liver Cirrhosis.

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • With 6 month of chronic liver disease history, and positive serum HBsAg

Exclusion criteria

  • Other chronic hepatitis and liver cirrhosis of non-hepatitis B

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

Trial contacts and locations

1

Loading...

Central trial contact

Lie-ming Xu, Professor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems